RENFORT PHARMA
No accounts filed yet
Bankruptcy probability
Bankruptcy probability within 12 months
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Director
Director
- founderdeed of 03-09-2025
- founderdeed of 03-09-2025
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:1027043522
Incorporation
Founding capital of €20,000, 100 shares · Founded by and · (director) and (director) appointed · published on 03-09-2025 · Gazette deed
First establishment
Drève du Bois de Neuville 83, Neupré
Official details
Source: KBO- Status
- Active since 01-09-2025Normal situation
- Activity
- Other business support servicesNACE 82990
- Establishment unit
- 2.377.915.6064121 Neupré, since 01-09-2025
- Financial year end
- 31 December
- Peppol
- Reachable since 04-11-2025
Insights on RENFORT PHARMA
RENFORT PHARMA has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. No annual accounts have been filed with the National Bank.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette.
Key facts about RENFORT PHARMA
- What is the company number of RENFORT PHARMA?
- The company number of RENFORT PHARMA is 1027.043.522. The VAT number is the same number with BE in front: BE 1027.043.522.
- Where is RENFORT PHARMA based?
- The registered office is at Drève du Bois de Neuville 83, 4121 Neupré.Company details
- What does RENFORT PHARMA do?
- According to the KBO register, the main activity is other business support services (NACE 82990).
- What is the legal form of RENFORT PHARMA?
- RENFORT PHARMA is a private limited company (BV).
- When was RENFORT PHARMA founded?
- RENFORT PHARMA was founded on 01-09-2025.
- Is RENFORT PHARMA still active?
- Yes, RENFORT PHARMA is an active enterprise in the KBO register.
- When are the next annual accounts of RENFORT PHARMA due?
- RENFORT PHARMA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See who is behind this young company and which other companies they have.Network investigator See this company's board, registered office and name on a given date.Company as of a date
See how customers, suppliers and banks see your own company and what to improve first.